Cargando…

Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine

BACKGROUND: Marburg virus (MARV) is the causative agent of Marburg virus disease (MVD) which has a case fatality rate up to ∼90% in humans. Recently, there were cases reported in Guinea and Ghana highlighting this virus as a high-consequence pathogen potentially threatening global public health. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Donnell, Kyle L., Feldmann, Friederike, Kaza, Benjamin, Clancy, Chad S., Hanley, Patrick W., Fletcher, Paige, Marzi, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947254/ https://www.ncbi.nlm.nih.gov/pubmed/36774693 http://dx.doi.org/10.1016/j.ebiom.2023.104463

Ejemplares similares

Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease
por: Marzi, Andrea, et al.
Publicado: (2021)

Single-dose VSV-based vaccine protects against Kyasanur Forest disease in nonhuman primates
por: Bhatia, Bharti, et al.
Publicado: (2023)

Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccine
por: Furuyama, Wakako, et al.
Publicado: (2021)

Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins
por: O’Donnell, Kyle L., et al.
Publicado: (2022)

Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infection
por: Fletcher, Paige, et al.
Publicado: (2023)

Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine
por: Furuyama, Wakako, et al.
Publicado: (2022)

Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation
por: Marzi, Andrea, et al.
Publicado: (2019)

VSV-Based Vaccines Reduce Virus Shedding and Viral Load in Hamsters Infected with SARS-CoV-2 Variants of Concern
por: O’Donnell, Kyle L., et al.
Publicado: (2022)

Transcriptional profiling of immune responses in NHPs after low-dose, VSV-based vaccination against Marburg virus
por: Prator, Cecilia A., et al.
Publicado: (2023)

Optimization of single dose VSV-based COVID-19 vaccination in hamsters
por: O’Donnell, Kyle L., et al.
Publicado: (2021)

Optimization of Single-Dose VSV-Based COVID-19 Vaccination in Hamsters
por: O’Donnell, Kyle L., et al.
Publicado: (2022)

Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2014)

Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model
por: de Wit, Emmie, et al.
Publicado: (2022)

Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge
por: Marzi, Andrea, et al.
Publicado: (2019)

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
por: Foster, Stephanie L., et al.
Publicado: (2022)

Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates
por: Brannan, Jennifer M., et al.
Publicado: (2019)

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge
por: Woolsey, Courtney, et al.
Publicado: (2022)

A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge
por: Domi, Arban, et al.
Publicado: (2018)

Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
por: Marzi, Andrea, et al.
Publicado: (2016)

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
por: Mire, Chad E., et al.
Publicado: (2013)

Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
por: Menicucci, Andrea R., et al.
Publicado: (2019)

UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates
por: Rosenke, Kyle, et al.
Publicado: (2021)

Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates
por: Woolsey, Courtney, et al.
Publicado: (2018)

Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever
por: Marzi, Andrea, et al.
Publicado: (2012)

UK B.1.1.7 variant exhibits increased respiratory replication and shedding in nonhuman primates
por: Rosenke, K., et al.
Publicado: (2021)

Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
por: Blaney, Joseph E., et al.
Publicado: (2013)

Development of a nonhuman primate model for mammalian bornavirus infection
por: Schlottau, Kore, et al.
Publicado: (2022)

Computed Tomography Imaging for Monitoring of Marburg Virus Disease: a Nonhuman Primate Proof-Of-Concept Study
por: Sword, Jennifer, et al.
Publicado: (2023)

Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques
por: Marzi, Andrea, et al.
Publicado: (2023)

A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever
por: Marzi, Andrea, et al.
Publicado: (2016)

Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model
por: O'Donnell, Kyle L., et al.
Publicado: (2021)

Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model
por: O’Donnell, Kyle L., et al.
Publicado: (2021)

A VSV-based Zika virus vaccine protects mice from lethal challenge
por: Emanuel, Jackson, et al.
Publicado: (2018)

Marburg virus pathogenesis – differences and similarities in humans and animal models
por: Shifflett, Kyle, et al.
Publicado: (2019)

Ebola and Marburg virus vaccines
por: Reynolds, Pierce, et al.
Publicado: (2017)

Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus
por: Mire, Chad E., et al.
Publicado: (2016)

Aging in nonhuman primates /
Publicado: (1979)

Behavior of Nonhuman Primates
por: Southwick, Charles H.
Publicado: (1966)

Transcriptomic analysis reveals a previously unknown role for CD8(+) T-cells in rVSV-EBOV mediated protection
por: Menicucci, Andrea R., et al.
Publicado: (2017)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
por: de Wit, Emmie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t2j1ibjkoqehnqlaolqjqvibu0